GHRP-2 5mg

for: Growth Hormone & Fat Loss.

GHRP-2 (Growth Hormone Releasing Peptide-2) is a specialized research hexapeptide utilized primarily to investigate the stimulation of endogenous growth hormone secretion and its impact on metabolic homeostasis. As a potent agonist of the ghrelin receptor (GHS-R1a), it acts as a highly effective growth hormone secretagogue. Dragon Pharma provides GHRP-2 5mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of neuroendocrinology and metabolic research, GHRP-2 (Pralmorelin) has become a fundamental tool for investigators exploring the hypothalamic-pituitary-somatotropic axis. This synthetic hexapeptide is recognized for its high efficacy in triggering pulsatile growth hormone release by mimicking the action of endogenous ghrelin. Dragon Pharma provides GHRP-2 5mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex endocrine models.

As scientific inquiry into pituitary function, sarcopenia, and appetite regulation expands, the need for reliable GHS-R agonists like GHRP-2 has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of GHRP-2 5mg.

Molecular Characteristics and Chemical Profile

The structural integrity of GHRP-2 allows it to bind with high specificity to the growth hormone secretagogue receptor. Unlike earlier iterations of GHRPs, GHRP-2 is researched for its potent stimulatory effect with a more moderate impact on secondary hormones such as prolactin and cortisol.

• Chemical Identity: GHRP-2 (Pralmorelin)
• Sequence: D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
• Molecular Formula: C45H55N9O6
• Molecular Weight: 817.9 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

GHRP-2 Structure

Source: PubChem

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Somatotropic Signaling: Mapping the pathways of growth hormone pulse frequency and amplitude.
• Appetite Regulation: Investigating the "orexigenic" (appetite-stimulating) effects via the ghrelin receptor.
• Tissue Growth & Repair: Assessing the modulation of the IGF-1 axis for muscle and bone density studies.
• Cardiovascular Research: Studying the potential protective effects of GHS-R activation on cardiac myocytes.
• Immune Modulation: Researching the role of GH secretagogues in thymic rejuvenation and T-cell production.

Pathway and Mechanistic Context

The core value of GHRP-2 5mg in a laboratory setting is its dual-action mechanism. It acts directly on the pituitary gland while simultaneously stimulating hypothalamic neurons to inhibit somatostatin, the hormone responsible for stopping GH release.

The GHS-R1a Signaling Axis

Upon activation by GHRP-2, the ghrelin receptor initiates a signaling cascade that results in the rapid mobilization of intracellular calcium. This leads to the exocytosis of growth hormone stored in the pituitary somatotrophs.

Key Mechanistic Shifts:

• Endogenous GH Release: GHRP-2 mimics the "natural pulse" of growth hormone, providing a framework for studying physiological endocrine rhythms.
• IGF-1 Elevation: Sustained research models often observe a downstream increase in Insulin-like Growth Factor 1 (IGF-1), which mediates most of the anabolic effects of growth hormone.
• Metabolic Shifts: It is used to investigate changes in nitrogen retention and protein synthesis in catabolic state models.

Primary Research Applications

1. Growth Hormone Deficiency (GHD) Models

GHRP-2 is heavily utilized in studies involving pituitary function. Because it can differentiate between hypothalamic and pituitary defects, it is a primary tool for investigating the mechanics of GH secretion failure and potential restorative pathways.

Source: PubMed

Source: PubMed

2. Sarcopenia and Muscle Wasting Research

Known in research circles for its anabolic potential, GHRP-2 is used to observe how tissues adapt to increased GH/IGF-1 levels. Investigators study changes in lean body mass and the reversal of muscle atrophy in various disease-state models.

3. Orexigenic and Cachexia Studies

In research involving severe weight loss or "wasting syndrome," GHRP-2 is studied for its ability to stimulate appetite via the ghrelin pathway. Research models examine how GHRP-2 influences food intake and energy balance in calorie-deprived environments.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. GHRP-2 5mg is produced under strict laboratory conditions to ensure stability and potency.

• Lyophilization for Stability: The compound is supplied in a freeze-dried form, preserving the delicate hexapeptide structure against degradation during transit.
• Rigorous Analytical Verification: Every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify that the purity exceeds 99% and the chemical signature matches the verified Pralmorelin profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.

Author:

All information was searched/edited by Dr. S. Edwin, and Dr. E. Croft who holds a doctorate from Case Western Reserve University School of Medicine